Page last updated: 2024-09-02

fingolimod hydrochloride and Polyomavirus Infections

fingolimod hydrochloride has been researched along with Polyomavirus Infections in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Billings, SD; Cohen, JA; Hudgens, CW; Ko, JS; Mahajan, KR; Tetzlaff, MT	1
Tyor, WR; Vargas, DL	1

Reviews

1 review(s) available for fingolimod hydrochloride and Polyomavirus Infections

Article	Year
Update on disease-modifying therapies for multiple sclerosis. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2017, Volume: 65, Issue:5 Topics: Administration, Oral; Alemtuzumab; Antibodies, Monoclonal, Humanized; Crotonates; Daclizumab; Dimethyl Fumarate; Drug Approval; Fingolimod Hydrochloride; Glatiramer Acetate; Humans; Hydroxybutyrates; Immunoglobulin G; Immunologic Factors; Infusions, Intravenous; JC Virus; Leukoencephalopathy, Progressive Multifocal; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Nitriles; Polyomavirus Infections; Recurrence; Toluidines; Treatment Outcome; Tumor Virus Infections; United States; United States Food and Drug Administration	2017

Article

Year

Update on disease-modifying therapies for multiple sclerosis.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2017, Volume: 65, Issue:5

Topics: Administration, Oral; Alemtuzumab; Antibodies, Monoclonal, Humanized; Crotonates; Daclizumab; Dimethyl Fumarate; Drug Approval; Fingolimod Hydrochloride; Glatiramer Acetate; Humans; Hydroxybutyrates; Immunoglobulin G; Immunologic Factors; Infusions, Intravenous; JC Virus; Leukoencephalopathy, Progressive Multifocal; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Nitriles; Polyomavirus Infections; Recurrence; Toluidines; Treatment Outcome; Tumor Virus Infections; United States; United States Food and Drug Administration

2017

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Polyomavirus Infections

Article	Year
Merkel cell carcinoma with fingolimod treatment for multiple sclerosis: A case report. Multiple sclerosis and related disorders, 2017, Volume: 17 Topics: Carcinoma, Merkel Cell; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Male; Merkel cell polyomavirus; Middle Aged; Multiple Sclerosis; Polyomavirus Infections; Skin Neoplasms	2017